What is inclusion body myositis? 

Inclusion body myositis (IBM) is a rare, progressive inflammatory muscle disease that leads to muscle weakness and wasting, particularly in the limbs. Unlike other inflammatory myopathies that can affect children or younger adults, IBM typically presents in people over the age of 50. The condition progresses slowly over many years, often making it difficult for individuals to notice the changes until daily activities like walking or gripping objects become noticeably challenging. Understanding the nature of this condition is a key step in accessing appropriate specialist care within the UK healthcare system. 

What We’ll Discuss in This Article 

• Defining inclusion body myositis and its unique characteristics. 

• Common symptoms involving the hands, fingers, and thighs. 

• How IBM differs from other inflammatory muscle conditions. 

• The typical age of onset and pattern of progression. 

• Diagnostic procedures used by specialists in the UK. 

• General management strategies to support mobility and safety. 

Understanding Inclusion Body Myositis 

Inclusion body myositis is a long-term inflammatory muscle condition that causes the voluntary muscles to gradually weaken and waste away due to a combination of inflammation and protein buildup in the cells. It is classified as an inflammatory myopathy, but it is unique because it also involves degenerative changes in the muscle fibres. This means that while the immune system is involved, the muscle cells themselves also show signs of premature damage or ageing. In the United Kingdom, it is recognised as the most common inflammatory muscle disease in people over the age of 50, yet it remains relatively rare in the wider population. 

The name of the condition comes from the “inclusion bodies” found within the muscle cells when viewed under a microscope. These are small clumps of proteins that should normally be cleared away by the body. In IBM, these proteins accumulate and interfere with the muscle’s ability to function and repair itself. This dual process of inflammation and degeneration is why the condition is often more difficult to manage than other forms of myositis that respond more readily to immune-suppressing treatments. 

Symptoms and Pattern of Weakness 

The symptoms of inclusion body myositis usually begin subtly and affect specific muscle groups, most notably the finger flexors and the quadriceps at the front of the thighs. 

Patients often first notice difficulty with tasks requiring a strong grip, such as opening jars, using a key, or fastening buttons. Because the thigh muscles weaken, individuals may also find themselves tripping more often or struggling to stand up from a low chair or the toilet without assistance. 

Another distinctive feature of IBM is that the weakness can be asymmetrical, meaning it might affect one side of the body more significantly than the other. For example, one leg may feel much weaker than the other, or one hand may lose its grip strength faster. This is different from many other muscle diseases, where the weakness is typically equal on both sides. As the condition progresses, the muscles in the forearms and the front of the lower legs may visibly waste away, leading to a thinner appearance of the limbs. 

Progression and Daily Impact 

Unlike some other muscle conditions that may flare up and settle down, inclusion body myositis follows a steady and slow progression over many years. Polymyositis and dermatomyositis are other types of myositis, but inclusion body myositis is distinct because it progresses more slowly and often involves specific muscles like those used for swallowing. This gradual decline means that many people adapt their lifestyle slowly, sometimes delaying a medical consultation until they experience a significant fall or persistent physical limitation. 

Over time, the weakness can spread to other areas, including the muscles of the throat. This leads to a condition known as dysphagia, or difficulty swallowing. Patients may notice they are coughing more frequently while eating or that food feels as though it is getting stuck. Because the progression is so slow, the impact on life expectancy is generally minimal, but the impact on independence and mobility can be substantial, eventually requiring the use of walking aids or a wheelchair for longer distances. 

IBM Compared to Other Myositis Types 

While inclusion body myositis shares some features with other inflammatory myopathies, it is often more difficult to treat and has a different pattern of muscle involvement. 

Feature	Inclusion Body Myositis (IBM)	Polymyositis/Dermatomyositis
Typical Age	Usually over 50 years old.	Can affect children and adults.
Primary Muscles	Fingers, forearms, and thighs.	Shoulders, hips, and neck.
Symmetry	Often asymmetrical (one side worse).	Usually symmetrical (both sides equal).
Progression	Very slow and steady.	Often more rapid (weeks/months).
Treatment Response	Often resistant to steroids.	Usually responds well to steroids.

The resistance to traditional steroid treatment is a major clinical hallmark of IBM. In other forms of myositis, high doses of corticosteroids often lead to a rapid improvement in strength. In IBM, steroids may slightly reduce inflammation but rarely lead to a significant or lasting gain in muscle power. This is because the degenerative protein clumping in the muscle cells is not addressed by immune suppression alone. 

Diagnosis and Specialist Testing 

Diagnosing inclusion body myositis requires a combination of clinical examination and specialist tests to identify the characteristic inclusion bodies within the muscle tissue. A diagnosis of inclusion body myositis is often confirmed through a muscle biopsy, where a small sample of tissue is examined for specific protein clumps and signs of inflammation. This procedure is essential because the blood tests used to detect muscle damage, such as the creatine kinase (CK) test, often show only slightly elevated levels in IBM, which can be misleading. 

In the UK, the diagnostic process usually involves a referral to a neurologist or a rheumatologist with an interest in neuromuscular disorders. In addition to a biopsy, doctors may perform an electromyography (EMG) test. This involves inserting a fine needle into the muscle to record its electrical activity. The pattern of activity in IBM is often a mix of “myopathic” and “neurogenic” signals, reflecting the complex damage to the muscle fibres. MRI scans of the legs may also be used to look for specific patterns of muscle wasting and fatty replacement in the thighs. 

Managing Mobility and Safety 

There is currently no cure for inclusion body myositis, so management focuses on maintaining physical function and ensuring the safety of the individual within their home environment. Physiotherapy and occupational therapy are essential for helping people with inclusion body myositis maintain their strength for as long as possible and adapt their daily routines. These professionals can provide tailored exercise programmes that focus on balance and preserving the muscle mass that remains. 

Safety at home is a priority, as the weakness in the quadriceps can lead to “sudden knee buckling,” which causes falls. Occupational therapists can assess the home for risks and suggest adaptations such as grab rails, walk-in showers, or stairlifts. For those with significant hand weakness, adaptive tools for the kitchen and bathroom can help maintain independence. If swallowing becomes an issue, a speech and language therapist can provide advice on changing food textures or using specific techniques to make eating safer and more comfortable. 

Conclusion 

Inclusion body myositis is a slow-progressing muscle condition that primarily affects older adults, leading to weakness in the hands and thighs. While it does not always respond to standard anti-inflammatory treatments, specialist support from the NHS can help manage symptoms and preserve independence. Identifying the signs early is vital for preventing injuries from falls and ensuring long-term safety. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T) 

This guide provides factual information on inclusion body myositis in alignment with NHS and NICE clinical standards for patient education. It was reviewed by Dr. Stefan Petrov, a UK-trained physician with experience in general medicine, surgery, and emergency care. The content aims to help the public understand the symptoms and diagnostic pathways for rare muscle conditions in the UK.